Cargando…
Programmed cell removal by calreticulin in tissue homeostasis and cancer
Macrophage-mediated programmed cell removal (PrCR) is a process essential for the clearance of unwanted (damaged, dysfunctional, aged, or harmful) cells. The detection and recognition of appropriate target cells by macrophages is a critical step for successful PrCR, but its molecular mechanisms have...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086865/ https://www.ncbi.nlm.nih.gov/pubmed/30097573 http://dx.doi.org/10.1038/s41467-018-05211-7 |
_version_ | 1783346573887930368 |
---|---|
author | Feng, Mingye Marjon, Kristopher D. Zhu, Fangfang Weissman-Tsukamoto, Rachel Levett, Aaron Sullivan, Katie Kao, Kevin S. Markovic, Maxim Bump, Paul A. Jackson, Hannah M. Choi, Timothy S. Chen, Jing Banuelos, Allison M. Liu, Jie Gip, Phung Cheng, Lei Wang, Denong Weissman, Irving L. |
author_facet | Feng, Mingye Marjon, Kristopher D. Zhu, Fangfang Weissman-Tsukamoto, Rachel Levett, Aaron Sullivan, Katie Kao, Kevin S. Markovic, Maxim Bump, Paul A. Jackson, Hannah M. Choi, Timothy S. Chen, Jing Banuelos, Allison M. Liu, Jie Gip, Phung Cheng, Lei Wang, Denong Weissman, Irving L. |
author_sort | Feng, Mingye |
collection | PubMed |
description | Macrophage-mediated programmed cell removal (PrCR) is a process essential for the clearance of unwanted (damaged, dysfunctional, aged, or harmful) cells. The detection and recognition of appropriate target cells by macrophages is a critical step for successful PrCR, but its molecular mechanisms have not been delineated. Here using the models of tissue turnover, cancer immunosurveillance, and hematopoietic stem cells, we show that unwanted cells such as aging neutrophils and living cancer cells are susceptible to “labeling” by secreted calreticulin (CRT) from macrophages, enabling their clearance through PrCR. Importantly, we identified asialoglycans on the target cells to which CRT binds to regulate PrCR, and the availability of such CRT-binding sites on cancer cells correlated with the prognosis of patients in various malignancies. Our study reveals a general mechanism of target cell recognition by macrophages, which is the key for the removal of unwanted cells by PrCR in physiological and pathophysiological processes. |
format | Online Article Text |
id | pubmed-6086865 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-60868652018-08-13 Programmed cell removal by calreticulin in tissue homeostasis and cancer Feng, Mingye Marjon, Kristopher D. Zhu, Fangfang Weissman-Tsukamoto, Rachel Levett, Aaron Sullivan, Katie Kao, Kevin S. Markovic, Maxim Bump, Paul A. Jackson, Hannah M. Choi, Timothy S. Chen, Jing Banuelos, Allison M. Liu, Jie Gip, Phung Cheng, Lei Wang, Denong Weissman, Irving L. Nat Commun Article Macrophage-mediated programmed cell removal (PrCR) is a process essential for the clearance of unwanted (damaged, dysfunctional, aged, or harmful) cells. The detection and recognition of appropriate target cells by macrophages is a critical step for successful PrCR, but its molecular mechanisms have not been delineated. Here using the models of tissue turnover, cancer immunosurveillance, and hematopoietic stem cells, we show that unwanted cells such as aging neutrophils and living cancer cells are susceptible to “labeling” by secreted calreticulin (CRT) from macrophages, enabling their clearance through PrCR. Importantly, we identified asialoglycans on the target cells to which CRT binds to regulate PrCR, and the availability of such CRT-binding sites on cancer cells correlated with the prognosis of patients in various malignancies. Our study reveals a general mechanism of target cell recognition by macrophages, which is the key for the removal of unwanted cells by PrCR in physiological and pathophysiological processes. Nature Publishing Group UK 2018-08-10 /pmc/articles/PMC6086865/ /pubmed/30097573 http://dx.doi.org/10.1038/s41467-018-05211-7 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Feng, Mingye Marjon, Kristopher D. Zhu, Fangfang Weissman-Tsukamoto, Rachel Levett, Aaron Sullivan, Katie Kao, Kevin S. Markovic, Maxim Bump, Paul A. Jackson, Hannah M. Choi, Timothy S. Chen, Jing Banuelos, Allison M. Liu, Jie Gip, Phung Cheng, Lei Wang, Denong Weissman, Irving L. Programmed cell removal by calreticulin in tissue homeostasis and cancer |
title | Programmed cell removal by calreticulin in tissue homeostasis and cancer |
title_full | Programmed cell removal by calreticulin in tissue homeostasis and cancer |
title_fullStr | Programmed cell removal by calreticulin in tissue homeostasis and cancer |
title_full_unstemmed | Programmed cell removal by calreticulin in tissue homeostasis and cancer |
title_short | Programmed cell removal by calreticulin in tissue homeostasis and cancer |
title_sort | programmed cell removal by calreticulin in tissue homeostasis and cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086865/ https://www.ncbi.nlm.nih.gov/pubmed/30097573 http://dx.doi.org/10.1038/s41467-018-05211-7 |
work_keys_str_mv | AT fengmingye programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT marjonkristopherd programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT zhufangfang programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT weissmantsukamotorachel programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT levettaaron programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT sullivankatie programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT kaokevins programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT markovicmaxim programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT bumppaula programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT jacksonhannahm programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT choitimothys programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT chenjing programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT banuelosallisonm programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT liujie programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT gipphung programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT chenglei programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT wangdenong programmedcellremovalbycalreticulinintissuehomeostasisandcancer AT weissmanirvingl programmedcellremovalbycalreticulinintissuehomeostasisandcancer |